All Health Care News
Top stories summarized by our editors
12/14/2018

A survey about the knowledge and beliefs of nurses in home health care regarding infection control practices in the American Journal of Infection Control found 60% said employers made it easy to stay home when ill. And 69.6% said they wore eye protection during procedures involving possible contact with blood products or body fluids.

12/14/2018

Patients with chronic myeloid leukemia who are undergoing tyrosine kinase inhibitor therapy were able to conceive and bear children based on data from 166 cases -- 106 conceptions involving male patients and 60 pregnancies in female patients. The findings were presented at the 2018 American Society of Hematology's 2018 annual meeting.

12/14/2018

A study of 959 breast cancer patients found that 38 of 83 women with genetic defects linked to breast cancer would not have been tested under guidelines from the National Comprehensive Cancer Network. The findings were published in the Journal of Clinical Oncology.

12/14/2018

The FDA withdrew a proposed rule that would have required generic-drug makers to monitor patient safety and update labels with new safety data regardless of updates to the reference product's label. Some stakeholders had expressed concern that the rule could have undermined public confidence in generics and led to higher prices and confusion among patients and physicians.

Full Story:
Regulatory Focus
More Summaries:
FDA
12/14/2018

Biotechnology Innovation Organization Chair John Maraganore urged drugmakers to pledge to not increase drug prices. Maraganore, who is also CEO of Alnylam Pharmaceuticals, said that "[T]he industry can do better, and Alnylam has stood uniquely to look at things like drug price increases and say 'no, we aren't going to do drug price increases."

Full Story:
BioPharma Dive
12/14/2018

The US Patent Trial and Appeal Board rejected Sanofi's claims that Mylan infringed patents on Lantus long-acting insulin, but a Sanofi spokesman said the decision is unlikely to change the market entry time of Mylan's competing product.

Full Story:
Reuters
More Summaries:
Sanofi, Appeal Board, Mylan
12/14/2018

Catalyst Pharmaceuticals plans to set a list price of $375,000 a year on Firdapse, which the FDA approved last month to treat Lambert-Eaton myasthenic syndrome. The drug has been available for years at a few hundred dollars per month through compounding pharmacies.

12/14/2018

Creative and healthy holiday gifts for friends and family can include less common foods and ingredients, such as matcha green tea, spices, aged balsamic vinegar, local honey and avocados, writes registered dietitian nutritionist Ellie Krieger. "If you know someone who loves to bake, for example, you could create a gift box filled with warming, sweet spices such as cinnamon and nutmeg, plus extracts such as vanilla and peppermint," Krieger says.

More Summaries:
Ellie Krieger
12/14/2018

It's possible to manage ad costs and improve results on Facebook with more precise targeting. Ronald Dod reviews several ways to begin identifying niche audiences.

Full Story:
Social Media Examiner
More Summaries:
Facebook, Ronald Dod
12/14/2018

Banner Health said it had 297,613 fewer ICU days than expected and saved an estimated 15,000 lives from 2006 to 2018 using its tele-ICU, intensivists, IT and advanced analytics. Avera Health's Avera eCARE ICU program saved the health system $62 million due to shorter lengths of stay.

Full Story:
Healthcare IT News
More Summaries:
Intensivists, Banner Health